Table 5.
Proposed treatments for CHS
Proposed treatment | Supportive evidence | Author | Study design | GRADE rating |
---|---|---|---|---|
Cessation of cannabis | Cessation of cannabis led to resolution of symptoms in 30 of 31 patients | Wallace [10] | Case series | Very low |
Among 10 CHS patients with follow-up, 30% did not abstain and continued to have symptoms and 60% stopped using and had complete resolution of symptoms. One patient experienced no symptomatic improvement with self-reported abstinence. | Simonetto [16] | Case series | Very low | |
Among 10 patients, 7 of 10 abstained and had resolution of symptoms. Three patients did not and illness continued. Three patients rechallenged themselves after a period of abstinence, and all suffered a return to illness | Allen [6] | Case series | Very low | |
Application of capsaicin cream to the abdomen | Five CHS patients experienced near complete resolution of symptoms after application of topical capsaicin cream to the abdomen | LaPoint [168] | Case series | Very low |
Case report of dramatic relief of symptoms in CHS patient with topical application of capsaicin | Biary [169] | Case report | Very low | |
Dopamine antagonists | Δ9-THC increases dopamine synthesis, turnover, and efflux and dopamine cell firing. Δ9-THC withdrawal, induced by abrupt discontinuation of chronic Δ9-THC treatment or administration of rimonabant, results in decreased dopamine efflux and neurotransmission | Schulze [103] | Experimental model | Very low |
CHS patient received 5 mg haloperidol and experienced complete resolution of symptoms within 1 h | Hickey [40] | Case report | Very low | |
Avoidance of opiate-based medications | Opioid analgesic use is associated with bowel dysfunction, and GI side effects have been reported in up to 47% of opioid-treated patients | Argoff [188] | Review | Very low |
Opiates should be used with caution as they have the potential to cause emesis | Galli [170] | Case report | Very low |